Keywords: nrti-sparing, approach, highlighted, new, data, first, head-to-head
NRTI-sparing approach highlighted by new data
Article | 28 August 2006
In the first head-to-head comparison between two commonly-used HIV treatments, researchers from the Universirty of Pittsburgh found that one "side-effect ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- SciClone gains China rights to Zensun's Neucardin
